Sunday, June 28, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 567 of 1,261
  1. US 9968669

    Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

    The United States of America as represented by the Secretary of the Army · Granted May 15, 2018 · Expires May 10, 2038

    granted
  2. US 9968664

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted May 15, 2018 · Expires May 10, 2038

    granted
  3. US 9968693

    Small molecule imaging of fungi by positron emission tomography scanning

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 15, 2018 · Expires May 10, 2038

    granted
  4. US 9970006

    Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes

    Alnylam Pharmaceuticals, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  5. US 9969975

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  6. US 9968644

    Traditional chinese medicine composition for sober-up and hepatic protection and a process for preparing the same

    INFINITUS (CHINA) COMPANY LTD. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  7. US 9968642

    Compositions and methods for treatment of pain

    Northwestern University · Granted May 15, 2018 · Expires May 10, 2038

    granted
  8. US 9968613

    Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted May 15, 2018 · Expires May 10, 2038

    granted
  9. US 9968641

    Method to suppress the systemic toxicity of chemotherapeutic drugs

    UNITED ARAB EMIRATES UNIVERSITY · Granted May 15, 2018 · Expires May 10, 2038

    granted
  10. US 9970059

    Survival predictor for diffuse large B cell lymphoma

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted May 15, 2018 · Expires May 10, 2038

    granted
  11. US 9968595

    Pharmaceutical compositions of therapeutically active compounds

    Agios Pharmaceuticals, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  12. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  13. US 9968586

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted May 15, 2018 · Expires May 10, 2038

    granted
  14. US 9968612

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  15. US 9968587

    Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 15, 2018 · Expires May 10, 2038

    granted
  16. US 9970037

    Methods and materials for making simvastatin and related compounds

    The Regents of the University of California · Granted May 15, 2018 · Expires May 10, 2038

    granted
  17. US 9969998

    Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

    HALOZYME, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  18. WO 2018083171

    COMPOSÉS SPIRO EN TANT QUE MODULATEURS DE S1P

    ABBVIE DEUTSCHLAND [DE] · Granted May 11, 2018 · Expires May 6, 2038

    granted
  19. US 9962352

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 8, 2018 · Expires May 3, 2038

    granted
  20. US 9962366

    Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

    Amazentis SA · Granted May 8, 2018 · Expires May 3, 2038

    granted
  21. US 9962377

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted May 8, 2018 · Expires May 3, 2038

    granted
  22. US 9962385

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  23. US 9962448

    Compounds and methods for targeted immune system delivery

    Northwestern University · Granted May 8, 2018 · Expires May 3, 2038

    granted
  24. US 9963478

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.